Philippe Spiess, MD, of Moffitt Cancer Cancer, highlights multiple abstracts from a poster session on penile and testicular cancer that he chaired at the AUA 2024 Annual Meeting, including prevalence of TERT expression in penile cancer patients as well as a statistically significant increase in TROP-2 mRNA expression levels in PSCC patients.
Dr. Spiess comments on the likelihood that TROP-2-targeted ADCs may emerge as a promising therapeutic intervention for these patients.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.